Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.15 | 41.64 |
| PEG Ratio (TTM) | 0.42 | 7.42 |
| P/S Ratio (TTM) | N/A | 4.11 |
| P/B Ratio (TTM) | 0.84 | 7.29 |
| P/FCF Ratio (TTM) | 3.87 | 65.82 |
| Price to 5YR AVG Earnings Ratio | -0.20 | 47.13 |
| Price to 5YR AVG FCF Ratio | -1.82 | 89.77 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -4.90% | 5.10% |
| ROE (TTM) | -17.31% | 19.50% |
| Net Profit Margin (TTM) | N/A | 5.19% |
| ROIC 5YR AVG | -13.67% | 9.59% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -311.70% | -33.38% | -21.84% |
| Revenue | 172.80% | 41.93% | 6.83% |
| Net Income | -340.50% | 69.23% | 62.26% |
| Cash Flow | 113.23% | -48.57% | 10.52% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.03 | 0.91 |
| Quick Ratio (TTM) | 0.03 | 0.87 |
| D/E Ratio (TTM) | 0.00 | 1.55 |
| Interest Coverage (TTM) | N/A | 9.52 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 2.91 |
| LTL to 5YR AVG FCF | N/A | 28.69 |
| Shares Outstanding Growth 5YR AVG | 106.80% | 0.02% |